Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-28EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
The EMA authorizes Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes, obesity, and overweight conditions.
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight [Phase 2]
Phase 2b trial results for MET097 in adults with obesity or overweight have been completed and results posted.
-
EMA approval · 2026-08-26EMA Authorised: Wegovy (semaglutide) — Novo Nordisk A/S
EMA authorises Wegovy (semaglutide) by Novo Nordisk A/S for obesity and overweight.
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
Phase 2/3 trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating and obesity/overweigh…
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Update: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Update: Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating pharmacological and behavioral maintenance treatments after bariatric surgery for loss-of-control eati…
-
EMA approval · 2026-08-25EMA Authorised: Ablymico (liraglutide) — STADA Arzneimittel AG
Ablymico (liraglutide) has been authorised by EMA for obesity and overweight indications.
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
A completed clinical trial investigating renal hemodynamics, energetics, and insulin resistance in subjects with type 2 diabetes, with resul…
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults [NA]
Clinical trial results examining metabolic adaptations to high-intensity interval training in obese adults with glucose intolerance.
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions [NA]
A completed clinical trial piloting a reinforcement learning tool to tailor just-in-time adaptive interventions for overweight and obesity m…
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans [NA]
A completed clinical trial evaluating how timing of sodium intake affects nocturnal sodium excretion and blood pressure in obese African Ame…
-
EMA approval · 2026-08-18EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
EMA authorised Mounjaro (tirzepatide) for therapeutic use in type 2 diabetes mellitus, obesity, and overweight conditions.
-
CLINICAL_TRIALS research · 2026-08-17Clinical Trial Results: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
A completed clinical trial examines pre-diagnosis GLP-1 receptor agonist use and post-cancer mortality in adults with obesity and type 2 dia…
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity [Phase 3]
Phase 3 clinical trial evaluating once-daily semaglutide tablets in East Asian individuals who are overweight or obese; results completed wi…
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism [NA]
A completed clinical trial comparing effects of ultra-processed versus unprocessed diets on energy metabolism in adults with healthy diet or…
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Update: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) [Phase 3]
Phase 3 cardiovascular outcome trial evaluating the safety of Survodutide (BI 456906) in overweight or obese individuals has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating pharmacological and behavioral strategies for non-responders after bariatric surgery, focusing on medi…
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
A completed clinical trial investigating anti-inflammatory properties of cannabis and their relation to insulin sensitivity in individuals w…
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Update: EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway [Phase 3]
Phase 3 study update for setmelanotide in patients with MC4R pathway gene variants; study completed.
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
A completed clinical trial evaluating cardiovascular outcomes in bariatric surgery patients with type 2 diabetes, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects [Phase 4]
Phase 4 trial results on semaglutide for appetite and eating behavior with long-term effects in obesity.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Time Restricted Eating for Weight Loss Maintenance [NA]
A completed clinical trial investigating time-restricted eating for weight loss maintenance in obesity; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight [Phase 3]
Phase 3 trial evaluating retatrutide (LY3437943) for type 2 diabetes in participants with obesity or overweight has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease [Phase 3]
Phase 3 trial update for Retatrutide (LY3437943) in adults with obesity and cardiovascular disease.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Effect of PDE5 Inhibition on Adipose Metabolism in Humans [Phase 2]
Phase 2 trial results assessing the effect of PDE5 inhibition on adipose metabolism in adults with obesity.